Better Therapeutics (BTTX) News Today $0.0001 0.00 (0.00%) (As of 01:57 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Janux Therapeutics Inc (JANX) Receives a Buy from BTIGNovember 7, 2024 | markets.businessinsider.comThis High-Flying Stock Just Became a Better BuyOctober 31, 2024 | fool.comBicara Therapeutics: A Buy Rating on Promising Clinical Progress and Financial FortitudeOctober 9, 2024 | markets.businessinsider.comBetter Therapeutics (OTC:BTTX) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comViking Therapeutics: Leaping Ahead In The Weight-Loss RaceAugust 22, 2024 | seekingalpha.comPTC Therapeutics Stock Earns RS Rating Upgrade To 83August 19, 2024 | msn.comBuy Rating Reaffirmed for Jasper Therapeutics on Strong Clinical Performance and Market PotentialAugust 15, 2024 | markets.businessinsider.comTG Therapeutics: Pressure On Briumvi To Perform As Share Price Hits ResistanceJuly 30, 2024 | seekingalpha.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Teleflex (TFX), Bioxcel Therapeutics (BTAI) and Prothena (PRTA)May 29, 2024 | markets.businessinsider.comClick Therapeutics Accelerates Expansion into Obesity and Cardiometabolic Disease With Acquisition of the Assets of Better Therapeutics, Inc.May 22, 2024 | businesswire.comBuy Rating Affirmed for Black Diamond Therapeutics Amid Strong Financials and Promising Clinical TrialsMay 16, 2024 | markets.businessinsider.comBuy Rating Affirmed for Leap Therapeutics on Strong Trial Prospects and Solid FinancialsMay 16, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Fortress Biotech (FBIO), GoodRx Holdings (GDRX) and Adaptimmune Therapeutics (ADAP)May 16, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Springworks Therapeutics (SWTX) and Becton Dickinson (BDX)May 6, 2024 | markets.businessinsider.comBuy Rating Affirmed for Context Therapeutics Amid Promising CTIM-76 Developments and Competitive EdgeMay 4, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Viking Therapeutics (VKTX) and Bristol-Myers Squibb (BMY)April 26, 2024 | markets.businessinsider.comPrecision Combination Therapy Better Controls High-Risk Subtypes of B-ALL in Mouse ModelsApril 10, 2024 | msn.comBetter Therapeutics plans employee layoffs, strategic reviewMarch 16, 2024 | uk.investing.comDow Dips Over 100 Points; Dick's Sporting Goods Earnings Top ViewsMarch 14, 2024 | markets.businessinsider.comBetter Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from NasdaqMarch 14, 2024 | businesswire.comTrading was temporarily halted for "BTTX" at 09:03 AM with a stated reason of "News pending."March 14, 2024 | marketbeat.comBetter Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health CentersMarch 5, 2024 | businesswire.comBetter Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)March 4, 2024 | finance.yahoo.comCAH Feb 2024 107.000 putFebruary 22, 2024 | finance.yahoo.comWhy Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionFebruary 20, 2024 | benzinga.comBetter Therapeutics Gets Breakthrough Device Designation For Cognitive Behavioral Therapy PlatformFebruary 20, 2024 | marketwatch.comBetter Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver DiseaseFebruary 20, 2024 | businesswire.comBuy Rating on Astria Therapeutics Supported by STAR-0215’s Promising Market Potential and Favorable Trial ResultsFebruary 6, 2024 | markets.businessinsider.comBetter Therapeutics Enters Rebate Agreement with Pharmacy Benefit ManagerFebruary 6, 2024 | marketwatch.comBetter Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes TreatmentFebruary 6, 2024 | finance.yahoo.comDavid Perry Bought 8.6% More Shares In Better TherapeuticsJanuary 18, 2024 | finance.yahoo.comBetter Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care AloneJanuary 17, 2024 | finance.yahoo.comBiora Therapeutics Provides Outlook for 2024January 16, 2024 | tmcnet.comBetter Therapeutics Insiders Added US$6.57m Of Stock To Their HoldingsJanuary 3, 2024 | finance.yahoo.comBetter Therapeutics applies for FDA breakthrough designation for NASH deviceJanuary 2, 2024 | msn.comBetter Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver DiseaseJanuary 2, 2024 | finance.yahoo.comBetter Therapeutics files to sell 20M shares of common stock for holdersDecember 13, 2023 | msn.comBetter Growth Stock: Viking Therapeutics or Iovance Biotherapeutics?December 12, 2023 | msn.comBetter Therapeutics amends debt facility, implements cost-saving measuresNovember 29, 2023 | msn.comBetter Therapeutics Strengthens Financial Position Through Amendment to Debt Facility and Implementation of Cost ReductionsNovember 28, 2023 | finance.yahoo.comFrost & Sullivan Honors Better Therapeutics with the 2023 Technology Innovation Leadership AwardNovember 14, 2023 | finance.yahoo.comBetter Therapeutics, Inc. (NASDAQ:BTTX) Q3 2023 Earnings Call TranscriptNovember 12, 2023 | finance.yahoo.comBetter Therapeutics: Q3 Earnings InsightsNovember 9, 2023 | benzinga.comBetter Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 09, 2023November 8, 2023 | finance.yahoo.comBetter Therapeutics to Participate in the American College of Lifestyle Medicine’s 2023 Annual ConferenceOctober 26, 2023 | finance.yahoo.comBetter Therapeutics Announces Launch of AspyreRx TM to Treat Adults with Type 2 DiabetesOctober 17, 2023 | businesswire.comBetter Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 DiabetesOctober 16, 2023 | finance.yahoo.comBetter Therapeutics Announces New Data Highlighting Concurrent Use of AspyreRx and GLP-1 Receptor Agonists to Treat Type 2 DiabetesOctober 11, 2023 | finance.yahoo.comBetter Therapeutics Announces Publication of LivVita Liver Disease Study Results in Gastro Hep AdvancesOctober 5, 2023 | finance.yahoo.comWhy Shares of BioXcel Therapeutics Fell This WeekSeptember 28, 2023 | msn.com Get Better Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTTX and its competitors with MarketBeat's FREE daily newsletter. Email Address When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again. Use this link to see Nvidia Unchained right away! BTTX Media Mentions By Week BTTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BTTX News Sentiment▼0.000.47▲Average Medical News Sentiment BTTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BTTX Articles This Week▼00▲BTTX Articles Average Week Get Better Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ACONW News AONC News CORBF News LFMDP News OTRKP News PIIIW News BFI News NTRA News FMS News HIMS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BTTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Better Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Better Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
